![]() |
市場調查報告書
商品編碼
1353414
床邊超音波全球市場規模、佔有率、產業趨勢分析報告:2023-2030 年最終用戶、按產品、地區的展望與預測Global Point-of-care Ultrasound Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Clinics, and Others), By Product (Cart-based, and Compact & Hand-held), By Regional Outlook and Forecast, 2023 - 2030 |
到 2030 年,床邊超音波市場規模預計將達到 32 億美元,預測期內年複合成長率為 13.8%。 2022年市場規模為1,60,085.6台,成長率為14.7%(2019-2022年)。
根據 KBV 基數矩陣中的分析,日立是該市場的先驅。 2020 年 3 月,日立發布了 ARIETTA 750,這是 ARIETTA超音波診斷平台系列的新型號。這種先進的超音波平台可適應各種治療環境的需求。 GE HealthCare Technologies, Inc.、FUJIFILM Sonosite, Inc. 和深圳邁瑞生物醫療電子有限公司等公司是該市場的主要創新者。
COVID-19 影響分析
由於旅行限制和國家封鎖,COVID-19 大流行擾亂了世界各地人們獲得醫療保健的機會。然而,在 COVID-19 爆發後,由於世界各地患者影像影像測試的增加,市場顯著成長。因此,床邊診斷影像測試已成為透過降低污染風險來控制 COVID-19 的基本要素。由於新冠病毒大流行,進行肺部超音波檢查的數量增加。這些測試用於鑒定COVID-19 患者共存的呼吸道疾病、評估肺部病變的嚴重程度並評估病理變化。 F
市場成長要素
重點參與企業推出超音波設備
由於攜帶性、顯著節省成本和提高臨床效果等優點,醫療保健領域對床邊超音波診斷設備的需求持續成長。在盧安達一家醫院進行的一項隊列研究發現,床邊超音波主要改善了藥物管理(42.4%)和身體定位(30%)。此外,市場參與企業對在開發中國家推出和開拓用於現場護理用途的超音波設備表現出極大的興趣,這將促進超音波設備的普及和普及,並刺激市場擴張。我是。
該領域的技術不斷進步
在整個預期期間存在許多市場擴張機會。這包括超音波心動圖、心包穿刺術、胸腔穿刺術、斷層掃描、血管通路和關節穿刺術以及靜脈導管插入術和外周靜脈導管插入術等程序的技術進步,以提高操作效率和患者健康。這是由於對移動點的需求不斷增加護理設備,例如。此外,各個組織為促進床邊超音波設備的使用和教育各領域的專業人員而發起的行銷活動也增強了市場擴張潛力。此外,醫生經常使用 POCUS 來評估心臟驟停。這些進步可能確保未來年度的市場成長。
市場抑制因素
攜帶式設備在照護端應用上的局限性
對使用這些小工具的擔憂源於對手持設備使用的限制。市面上已有的超音波設備(例如 Lumify 和 Vscan Air)用於診斷特定疾病,例如心血管問題或個人創傷。因此,這些工具無法支援 3D 或 4D影像以及患者體檢的其他元素。此外,低靈敏度和特異性、影像品質延遲和設備尺寸小等要素可能會限制患者疾病的診斷和臨床進展。此外,缺乏國家和國際組織為使用這些設備提供的培訓和認證計劃也是市場的抑制因素。
最終用戶前景
依最終用戶分類,市場分為醫院、診所等。 2022 年,診所業務在市場中佔據了重要的收入佔有率。推動 POCUS 在診所中越來越多使用的一個主要要素是,如果及早發現併發症,可能會節省醫療費用。臨床醫生可以使用POCUS來指導各種醫療操作,例如中心靜脈管放置、胸腔穿刺、鼻竇穿刺和關節抽吸,以確保準確性並降低併發症的風險。
產品展望
按產品,市場分為推車式及緊湊型及手持式。 2022 年,基於購物車的細分市場以最大的收入佔有率主導市場。以推車為基礎的系統通常配備先進的成像功能,例如彩色多普勒、頻譜多普勒、3D/4D 成像和彈性成像,從而可以進行更全面的診斷評估。
區域展望
從區域來看,我們對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年,北美地區的市佔率最高。推出尖端緊湊型超音波設備的主要公司正在要素市場成長。此外,醫療保健專業人員在照護端用途中擴大採用超音波設備也有助於北美市場的擴張。技術創新、臨床效益、教育機會和法規支援相結合,導致北美地區 POCUS 的使用增加。
The Global Point-of-care Ultrasound Market size is expected to reach $3.2 billion by 2030, rising at a market growth of 13.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,60,085.6 units, experiencing a growth of 14.7% (2019-2022).
Medical professionals utilize smaller equipment to diagnose respiratory diseases and injuries at the patient's bedside in intensive care units and emergency departments. Thus, the Compact & Hand-held segment will register approximately half of the share of the market by 2030. According to data released by National Health Service (NHS) England, 10.3 million ultrasound procedures were carried out in the U.K. in 2020. Portable, safe, and cost-effective small and hand-held technologies provide rapid outcomes for clinical decision-making. Furthermore, compared to traditional ultrasound machines, expenses for handheld devices are cheaper. The widespread acceptance of these devices was due to their prospective benefits, including non-invasiveness, high sensitivity, and rapid ultrasound interpretation across health centers.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The device offers a novel and adjustable work surface, to increase clinician ergonomics and productivity. Additionally, In November, 2022, Philips released the compact 5000 series. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Based on the Analysis presented in the KBV Cardinal matrix; Hitachi, Ltd. is the forerunner in the Market. In March, 2020, Hitachi, Ltd. revealed ARIETTA 750, the new model from the ARIETTA's diagnostic ultrasound platform series. This advanced ultrasound platform adapts to the needs of varied therapeutic settings. Companies such as GE HealthCare Technologies, Inc., FUJIFILM Sonosite, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are some of the key innovators in the Market.
COVID-19 Impact Analysis
Due to travel restrictions and national lockdowns, the COVID-19 pandemic hampered access to healthcare for the entire world's population. However, the market saw significant growth after the COVID-19 outbreak due to a rise in diagnostic imaging testing among patients across the globe. a result, bedside diagnostic imaging became an essential component of controlling COVID-19 by reducing the risk of contamination. As a result of the COVID pandemic, there was an increase in the number of lung ultrasound tests performed. These tests were utilized to identify co-occurring respiratory pathologies in COVID-19 patients, assess the severity of lung pathology, and evaluate pathological changes. F
Market Growth Factors
Emphasis on ultrasound device launches by major participants
Due to advantages such as portability, significantly cheaper cost, and increased clinical efficacy of these devices, the demand for ultrasound equipment for point-of-care applications continues to rise across healthcare specialties. In cohort research conducted in Rwanda hospitals, it was found that point-of-care ultrasound primarily modified the medications delivered (42.4%) and the disposition (30%). Furthermore, market participants focus a lot of attention on the launch and development of ultrasound devices in point-of-care applications in developing countries, which boosts ultrasound device accessibility and adoption, thereby fueling market expansion.
Increasing Technological advancements in the field
There are numerous opportunities for the market to expand throughout the anticipated period. This is due to technological advancements in procedures like echocardiography, pericardiocentesis, thoracentesis, tomography, vascular access, and arthrocentesis as well as the rising demand for mobile point-of-care devices like venous catheterization and peripheral venous catheterization to improve operational efficiency and patient health. Additionally, market expansion potential is fueled by marketing efforts launched by various organizations to promote the use of point-of-care ultrasound devices and educate professionals from various fields. Furthermore, doctors often employ POCUS to evaluate cardiac arrests. Such advances would guarantee the market's growth in the coming years.
Market Restraining Factors
Limitations of portable devices in point-of-care applications
Concerns about adopting these gadgets arise from the restrictions related to using hand-held devices. The ultrasound machines already in the market, such as Lumify and Vscan Air, are made to diagnose certain illnesses, like cardiovascular problems and trauma in individuals. Therefore, these tools cannot support 3D and 4D imaging as well as other components of the patient's physical examination. Furthermore, limitations in the diagnosis and clinical progression of diseases among patients may be caused by factors like low sensitivity and specificity, delayed image quality, and small devices. Additionally, the market is being constrained by the absence of training and certification programs offered by national and international organizations for using these devices.
End User Outlook
Based on end user, the market is trifurcated into hospitals, clinics, and others. The clinics segment garnered a significant revenue share in the market in 2022. The key driver of POCUS's growing use in clinics is the potential to save healthcare costs if complications are detected early. Clinicians can use POCUS to guide various medical procedures, such as central line placements, thoracentesis, paracentesis, and joint aspirations, ensuring precision and reducing the risk of complications.
Product Outlook
By product, the market is segmented into cart-based and compact & hand-held. In 2022, the cart-based segment dominated the market with the maximum revenue share. Cart-based systems often come equipped with a range of advanced imaging features, including color Doppler, spectral Doppler, 3D/4D imaging, and elastography, enabling more comprehensive diagnostic evaluations.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. Leading companies launching cutting-edge and small ultrasound equipment are responsible for the market's growth. The adoption of ultrasound equipment for point-of-care applications by medical professionals, which continues to rise, also contributed to the market expansion in North America. The combination of technological innovation, clinical benefits, educational opportunities, and regulatory support has fueled the increasing use of POCUS across North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
Recent Strategies Deployed in Point-of-care Ultrasound Market
Partnerships, Collaboration and Agreements:
Sep-2021: GE Healthcare joined hands with UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI. The images of an astronaut's heart in microgravity would be captured using the real-time AI guidance software of UltraSight and the portable GE Vscan AirTM, a high-performance, wireless pocket-sized color ultrasound from GE Healthcare.
Jan-2021: Hitachi entered into an agreement with Olympus Corporation, a manufacturer of optics and reprography products. With this agreement, the company aimed to offer better diagnostic and treatment to patients and healthcare professionals.
Product Launch and Product Expansions:
Jan-2023: FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The newest version of Sonosite POCUS, called Sonosite PX, offers the highest level of visual quality ever seen in a Sonosite system, as well as a number of features that help with workflow efficiency and a flexible form factor. The device offers a novel and adjustable work surface that can be employed in a horizontal or vertical position depending on the situational needs of the exam in order to increase clinician ergonomics and productivity.
Nov-2022: Philips released the compact 5000 series, a new compact ultrasound system. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Jun-2022: Mindray unveiled TEX20 Series, best-in-class Point of Care ultrasound system. With its patient-centered information solution, extraordinary image clarity, clinically oriented workflow, smart tools, and intelligent design, this ground-breaking point of care system, the TEX20 Series, dramatically alters the conventional perspective of POC ultrasonography from its predecessors. It offers all the details needed to make decisions for follow-up and quality control.
Mar-2021: GE Healthcare today unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging. The Venue Fit is the smallest system in the Venue Family from GE Healthcare, with a tiny footprint designed to fit in confined places, an easy-to-clean touchscreen, and straightforward scanning tools. The new Venue Fit ultrasound device enables healthcare professionals who work in constrained areas to get immediate imaging insights.
Mar-2021: GE Healthcare Vscan Air, hand-held ultrasound device. The new product is completely wireless, links to a smartphone app, and enables patients to safely access the images. Trained healthcare professionals can use the gadget to immediately test blood flow, gallbladder illness, and analyze and monitor Covid-19 through a lung exam.
Mar-2021: ALPINION MEDICAL SYSTEMS launched X-CUBE 90, High-Performance Ultrasound Diagnostic System. ALPINION separately created the imaging platform known as X+ Architecture, which is used in X-CUBE 90. Large-size data are quickly reorganized using the special algorithm used by ALPINION, resulting in the production of clear, high-resolution photographs.
Acquisitions and Merger:
Jul-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH. Through this acquisition, Mindray would significantly strengthen its international supply chain infrastructure and assist the expansion of our IVD business into medium- to large-sized customer sectors. Both companies will work together to realize synergies and increase value for our customers.
Sep-2021: GE Healthcare completed the acquisition of BK Medical, a company that offers ultrasound technology. The acquisition would help GE Healthcare expand its ultrasound offerings into surgical visualization and fuel the growth in precision health.
Market Segments covered in the Report:
By End User (Volume, Units, USD Million, 2019-2030)
By Product (Volume, Units, USD Million, 2019-2030)
By Geography (Volume, Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research